FOXO3 and cancer: Specifically, we propose that cancer induction of cachexiainvolves: i) decreased expression of PGC-1ß, which normally inhibits FoXOs; and ii)attenuated AKT activity, which both enable activation of FoXO3α and upregulate theexpression of atrogenes, which then facilitate muscle degradation.